Clinical trial
Randomized Trial Comparing Intravenous Iron Carboxymaltose, Intravenous Iron Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
NCT03957057 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial Comparing Intravenous Iron Carboxymaltose, Intravenous Iron Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
- Lead sponsor
- University Medical Centre Ljubljana
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 10, 2020
- Completion date
- June 15, 2022
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
iron-deficiency, postpartum anemia nos